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Introduction: Pectus excavatum is the most common congenital chest wall deformity and the depression of the
anterior chest wall, which compresses the internal organs. The aim of the present study is to investigate the effects
of pectus excavatum on blood laboratory findings.
Material and Methods: From March 2011 to December 2011, 71 patients with pectus excavatum who visited
Seoul Saint Mary Hospital for Nuss procedure were reviewed and analyzed. The blood samples were routinely taken
at the day before surgery and pectus bar removal was usually performed in 2 to 3 years after Nuss procedure.
To investigate the effects on blood laboratory findings, preoperative routine blood laboratory data and
postoperative changes of abnormal laboratory data were analyzed.
Results: Only lactate dehydrogenase (LDH), one of 26 separate routine laboratory tests, was abnormal and
significantly elevated than normal value (age <10, p = 0.008; age ≥10, p < 0.001). However, there was no significant
correlation between LDH levels and severities of pectus excavatum. The symmetric subgroup had significantly
higher LDH level than the asymmetric subgroup (p <0.001) and there was a significant decrease of LDH level after
correction of deformity (p = 0.017).
Conclusion: In conclusion, only LDH, one of the routine laboratory tests, was significantly elevated than normal
value, which was thought to be caused by etiologies of pectus excavatum and the compression of the internal
organs. Further studies on LDH including isoenzyme studies in patients with pectus excavatum will be needed,
and these studies will provide a deeper and wider comprehension of pectus excavatum.
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Pectus excavatum is the most common congenital chest
wall deformity and the depression of the anterior chest
wall, which compresses the lung and the heart [1-3].
Many studies on etiology, morphology and cardiopulmo-
nary compromises have been performed. However, there
are few studies on the blood laboratory findings of pa-
tients with pectus excavatum because most patients with
pectus excavatum are so asymptomatic and otherwise
healthy that no specific laboratory study is considered to
be necessary [1-3]. However, we assumed that the etiolo-
gies or the compressions of internal organs including the* Correspondence: kckmd@hanmail.net
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The aim of the present study is to investigate the effects of
pectus excavatum on blood laboratory findings. For this
purpose, we compiled and analyzed preoperative routine
blood laboratory results of the patients with pectus
excavatum who had visited Seoul Saint Mary Hospital
for Nuss operation, and analyzed postoperative changes
of abnormal laboratory data.Methods
From March 2011 to December 2011, 71 patients with
pectus excavatum who visited Seoul Saint Mary Hospital
for Nuss procedure were reviewed and analyzed. Inclusion
criteria for the present study were (1) preoperative diag-
nosis as pectus excavatum, (2) no combined other con-
genital anomaly or disease, (3) no other drug intake, and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Basic clinical characteristics of the patients
Mean SD
Age (year) 11.92 4.48
Haller index 4.39 1.48
Chest wall compression index 2.61 1.23
Cardiac compression index 4.20 1.40
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laboratory results (5) ages from 5 to 19 years old (6) no
definite inflammation or infection at the time of the
surgery for Nuss procedure and pectus bar removal.
To rule out the unknown effects on blood laboratory
findings, we excluded the following cases: (1) any drug
or medication intake (2) radiologic abnormalities except
pectus excavatum, such as a tumor, inflammation or
pneumonia. (3) any clinical symptoms, such as pain,
fever, etc. The surgery for pectus bar removal was usually
performed in 2 to 3 years after Nuss procedure, according
to the patients’ ages and conditions. To investigate the
effects of pectus excavatum on blood laboratory findings,
Preoperative routine blood laboratory data and postopera-
tive changes of abnormal laboratory data were analyzed.
The blood samples were routinely taken at the day be-
fore surgery (Nuss procedure and pectus bar removal).
The laboratory data taken at the day before Nuss pro-
cedure were defined as the preoperative ones and the
laboratory data at the day before pectus bar removal
were defined as the postoperative ones. Each patient
underwent single a laboratory study consisting of 26
separate routine tests. The laboratory data were divided
into gender and age. The reference laboratory ranges
used in the present study were based on the current
standardized test reference range at Seoul Saint Mary
Hospital. Wherever applicable, age and gender- spe-
cific ranges were defined. These reference ranges are
defined through varied methods, including healthyTable 2 Overall laboratory results (Complete blood count) of
Component measured Age (year) Sex Reference range
White blood cell(/μL) 5-6 6000-15000 78
7-12 4500-13500 73
13-19 5000-1000 58








Platelet (×103/ μL) 150-450 2person for regular checkups and outside data accumu-
lation. No patient’s data were excluded on the abnor-
mal blood test results. The 26 laboratory tests included
routine CBC (complete blood count) and blood chem-
istry. All laboratory tests were measured by standard
methods using an auto analyzer (Hitachi 7600–210;
Hitachi, Tokyo, Japan) and available assay kits (Sekisui
Medical Co., Ltd., Tokyo, Japan). To decide abnormal-
ity of the laboratory test results, all data were analyzed
with the simple T test and compared with the lower or
upper limit of reference range. The comparisons be-
tween subgroup were performed with the ANCOVA
(analysis of covariance). The relationship between sever-
ities of pectus excavatum and abnormal laboratory values
was analyzed with the Pearson correlation test. The se-
verity of pectus excavatum was defined as the Haller
index, the chest wall depression index, and the cardiac
compression index. The postoperative changes of ab-
normal laboratory data were analyzed with the paired
T test. All data were analyzed using the Statistical
Package of Social Sciences (SPSS) computer software
program, version 18.0 (Chicago, IL, USA). A p- value < 0.05
was considered to be statistically significant. The approval
from the Seoul Saint Mary's Hospital was obtained for
the present study (KC12RISI0826)
Results
We analyzed data from the overall 71 patients. The mean
age was 11.92 years (range 5–19 year). Male and female
patients were 55 and 16, respectively. Symmetric and
asymmetric type was 30 and 41, respectively. Basic clinical
characteristics of patients in the present study are sum-
marized in Table 1. Out of the total 1,697 separate tests,
the patients with pectus excavatum had 170 abnormal
laboratory values. These laboratory results are summarized
in Tables 2 and 3. Only lactate dehydrogenase (LDH),
one of the 26 separate laboratory tests, was statisticallythe patients













Table 3 Overall laboratory results (Blood chemistry) of the patients
Component measured Age(year) Sex Reference range Mean(SD) Total studied number Total abnormal value (%)
Blood urea nitrogen(mg/dl) 5-14 5-18 12.20(2.96) 48 4.2
15-19 7-18 13.06(3.02) 23 8.7
Creatinine (mg/dl) 5-14 0.3-1.0 0.54(0.13) 48 0
15-19 M 0.6-1.2 0.84(0.15) 21 0
F 0.5-1.1 0.60(0.06) 2 0
Total protein (g/dl) 5-7 6.1-7.9 6.91(0.50) 10 0
8-12 6.4-8.1 7.11(0.38) 17 0
13-19 6.6-8.2 6.95(0.51) 26 12.5
Albumin (g/dl) 5 3.9-5 4.46(0.16) 11 0
6- 4.0-5.3 4.46(0.25) 60 1.7
Aspartate aminotransferase (U/L) 5- 14-40 24.18(5.04) 71 0
Alanine aminotransferase (U/L) 5-45 14.97(4.39) 71 0
Alkaline phosphatase (U/L) 5-9 134-386 263.29(172.56) 14 7.1
10-15 M 116-483 266.14(106.71) 14 7.1
F 93-386 224.11(84.21) 9 11.1
16- M 58-237 91.56(37.21) 16 12.5
F 45-116 77.00 1 0
Total bilirubin (mg/dl) 0.47-1.58 0.59(0.40) 71 2.8
Direct bilirubin (mg/dl) 0.13-0.47 0.18(0.13) 71 4.2
Gamma glutamyl transpeptidase (U/L) 5-14 0-23 13.44(3.64) 32 3.1
15- M 11-50 21.17(6.13) 18 5.6
F 7-32 12.50(0.71) 2 0
Uric acid (mg/dl) 5 1.7-5.8 3.73(1.00) 7 0
6-11 2.2-6.6 4.05(0.86) 12 0
12- M 3.0-7.7 4.05(0.86) 27 3.7
F 2.7-5.7 4.62(0.30) 6 0
Calcium (mg/dl) 5-14 8.8-10.8 9.51(0.33) 48 0
15-19 8.4-10.2 9.35(0.30) 23 0
Phosphorous (mg/dl) 5-11 3.7-5.6 5.10(0.52) 20 15.0
12-15 2.9-5.4 4.85(0.53) 16 12.5
16-19 2.7-4.7 4.10(0.42) 17 5.9
Sodium (mEq/L) −14 138-145 141.13(1.66) 48 4.2
15- 136-146 140.65(1.90) 23 0
Potassium (mEq/L) 3.5-5.01 4.15(0.25) 71 0
Chloride (mEq/L) 98-106 103.83(1.94) 71 4.2
Lactate dehydrogenase (U/L) 5-9 150-500 540.32(64.78) 22 63.6
10-19 120-330 434.61(91.90) 49 87.8
Creatine phosphokinase (U/L) 5-130 107.49(32.91) 71 21.1
Amylase (U/L) 48-176 97.59(32.95) 52 1.9
Magnesium (mg/dl) 1.9-2.5 2.11(0.14) 71 4.2
Total cholesterol (mg/dl) 5-19 −170 143.92(23.83) 51 15.7
Ammonia (mcg/dl) 20-80 77.48(19.82) 52 40.4
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Table 4 Analysis of lactate dehydrogenase before Nuss procedure
Age(year) Reference range Mean(SD) 95% confidence interval of the difference p-value
Lactate dehydrogenase (U/L) 5-9 150-500 540.32(64.68) 11.64 ~ 68.99 0.008
10-19 120-330 434.61(91.90) 78.22 ~ 131.01 < 0.001
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(age <10 p = 0.008; age ≥10 p < 0.001) (Table 4, Figure 1),
and the other 25 separate laboratory findings were
statistically within normal range. However, there was
no significant correlation between LDH levels and sever-
ities of pectus excavatum (defined as Haller index, chest
wall depression index, and cardiac compression index).
A considerable number of patients’ hematocrit, creatine
phosphokinase level also increased, but there was no
statistical significance. Though there was no significant
difference of severity between symmetric and asymmetric
subgroup, the symmetric subgroup had significantly higher
LDH level than the asymmetric subgroup (p <0.001). There
was a significant decrease of LDH level after correction of
compression or depression (p = 0.017) (Table 5).
Discussion
Pectus excavatum is the most common congenital chest
wall deformity and the depression of the anterior chest
wall, which compresses the lung and heart [1-3]. Until
now, nearly all previous studies have been performed to
investigate its etiology, cardiopulmonary compromise,
morphology and surgical techniques. However, because
most patients with pectus excavatum are so asymptomatic
and otherwise healthy that no specific laboratory study
is considered to be necessary, there are few studies on
the blood laboratory findings of patients with pectusFigure 1 Lactate dehydrogenase levels in patients with pectus excava
significantly elevated than normal value (age <10, p = 0.008; age ≥10, p < 0
range (Horizontal lines: upper normal limits of lactate dehydrogenase levelexcavatum [1-3]. We assumed that the etiologies of pectus
excavatum or the compression of internal organs including
the heart and the lung could affect the blood laboratory
findings. To find out the effects of pectus excavatum on
laboratory findings, we analyzed the routine laboratory
tests, which were performed routinely before surgery
(Nuss procedure and pectus bar removal). These routine
laboratory tests were composed of 26 separate tests,
including complete blood count and blood chemistry
tests. Only lactate dehydrogenase (LDH), one of the
26 separate routine laboratory tests, had statistically
abnormal value and the other 25 separate laboratory
tests were statistically within normal range.
LDH is a cytoplasmic enzyme found in the cells of all
major organs, including the heart, the liver, the kidneys,
the skeletal muscle, the brain, red blood cells, and the
lung [4,5]. It is responsible for converting lactic acid into
pyruvic acid, an essential step in producing cellular energy
[4]. Because LDH is present in almost all body tissues,
LDH test is usually used to detect tissue damage or in-
flammation [6]. LDH level can be elevated when various
conditions, for example, hemolysis, drug, infection, renal
and liver disease, muscular dystrophy, various cancers or
tumorous condition and inflammation [5,7-12]. Because
the total serum LDH is a highly sensitive but nonspecific
test [4-6], the isoenzyme of LDH test is used to localize
the specific site of organs [4,6]. Also, determining LDHtum. Only lactate dehydrogenase was statistically abnormal and
.001) and the other laboratory findings were statistically within normal
according to ages).
Table 5 Analysis of postoperative lactate dehydrogenase




Difference (U/L) 33.441(77.87) 6.27- 60.61 0.017
(preoperative-
postoperative)
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portant enzymes (aspartate aminotransferase, alanine
aminotransferase, and creatine phosphokinase) provides
more accurate decisions [10]. However, because the
preoperative routine laboratory test did not include the
LDH isoenzyme tests, the isoenzyme patterns in patients
with pectus excavatum could not be analyzed. Also the
present study showed there were no abnormal findings in
aspartate aminotransferase, alanine aminotransferase, and
creatine phosphokinase.
Reference ranges for total LDH vary from laboratory
to laboratory [13]. In our hospital, the reference range
for age under 10 is under 500 units/L, and the reference
range for the age of 10 and older is under 330 units/L.
Beside these conditions mentioned above, LDH level can
be elevated in some clinical situations, such as heart
failure and pneumonia [4,14]. However, to our best know-
ledge, there is no report or study on LDH elevation in
patients with pectus excavatum yet. Of course, we con-
sidered the possibility that high LDH level might be
due to difficulty experienced during collection or handling
of the sample. Because the other laboratory results were
all normal, and careful monitoring was taken, we could
rule out the errors [15,16].
Evidently, the present study showed LDH level was sig-
nificantly elevated than the upper normal limit without any
correlation between LDH and severity of pectus excavatum
(defined as Haller index, chest wall depression index, and
cardiac compression index), and without other enzymes
abnormalities (aspartate aminotransferase, alanine ami-
notransferase, and creatine phosphokinase). In addition,
the symmetric subgroup had significantly higher LDH
level than the asymmetric subgroup and LDH level was
significantly decreased after the correction of deformity.
We propose here two hypotheses from the above find-
ings. Firstly, LDH elevation was caused by etiologies of
pectus excavatum and the compression of the internal
organs, which was demonstrated by irrelevance with
severity of pectus excavatum and a significant decrease
after correction of pectus excavatum. If LDH elevation
was caused by the compression of internal organ alone,
LDH level would be correlated with the degree of com-
pression and normalized after correction of compression.
Also if LDH elevation was not relevant to the compression
of internal organ, there would be no decrease of LDH
level after correction of pectus excavatum. Secondly,the musculoskeletal growth abnormality can elevate LDH
level. If LDH elevation was caused by the musculoskeletal
growth abnormality in patients with pectus excavatum,
LDH elevation in patients with pectus excavatum can pro-
vide another evidence to support the hypothesis that the
musculoskeletal growth abnormality is one of etiologies in
patients with pectus excavatum. Therefore, we assumed
that postoperative LDH were higher than normal value,
since causes or etiologies of pectus excavatum could not
be removed by Nuss procedure.
To find out the definite causes of LDH elevation, it is
important to know from what tissue the LDH was released
into the bloodstream, and isoenzyme pattern differences
from normal. However, because the routine preoperative
laboratory test did not include the isoenzyme of LDH test,
the definite causes for LDH elevation are not discovered
yet. Further studies on LDH, including isoenzyme pattern
analysis, will be needed to investigate the definite causes
of LDH elevation.
To our best knowledge, the present study is the first
and the systemic study on routine laboratory evaluations.
But there were a few limitations in this study. Firstly, the
present study is a retrospective, a small size, and a single
center study. The larger studies from multi-centers will
be needed. Secondly, because the routine preoperative
laboratory test did not include the isoenzyme of LDH
test, we do not still know the definite causes for LDH
elevation. Further studies on LDH, including isoenzyme
pattern analysis, will be needed to find out the exact
causes of LDH elevation.
Conclusion
Only LDH, one of the routine laboratory tests, was signifi-
cantly elevated than normal value, which was thought to be
caused by etiologies of pectus excavatum and the compres-
sion of the internal organs. Further studies on LDH includ-
ing an isoenzyme study in patients with pectus excavatum
will be needed, and these studies will provide a deeper and
wider comprehension of pectus excavatum.
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